PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast

Beth Sandy, MSN, CRNP, FAPO - Antibody–Drug Conjugates, the Ultimate Weapons Against Solid Tumors: Latest Progress, Future Possibilities, and Implications for Patient Care

12.06.2023 - By PVI, PeerView Institute for Medical EducationPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CE/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/BUC865. CME/NCPD/CE/CPE/AAPA credit will be available until December 9, 2024. Antibody–Drug Conjugates, the Ultimate Weapons Against Solid Tumors: Latest Progress, Future Possibilities, and Implications for Patient Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. SupportThis activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc. Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity. Faculty/Planner DisclosuresChair/PlannerBeth Sandy, MSN, CRNP, FAPO, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc. and Janssen Pharmaceuticals, Inc.Speakers Bureau participant with Amgen Inc.; AstraZeneca; Jazz Pharmaceuticals, Inc.; Lilly; Merck & Co., Inc.; and Takeda Pharmaceutical Company Limited. Faculty/PlannerJamie Carroll, APRN, CNP, MSN, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Lilly; Novartis Pharmaceuticals Corporation; Pfizer; Sermonix Pharmaceuticals; and Talzenna.Speakers Bureau participant with Horizon CME and OncLive. Faculty/PlannerElizabeth Prechtel Dunphy, DNP, RN, ANP-BC, AOCN, has a financial interest/relationship or affiliation in the form of:Speakers Bureau participant with Incyte. Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

More episodes from PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast